Tokai Pharmaceuticals (TKAI) IPO Surges Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Tokai Pharma (TKAI) Looks for More Post-IPO Gains
September 18, 2014 7:23 AM EDTTokai Pharma (Nasdaq: TKAI) is adding to Wednesday's gains.
Ahead of the bell, Tokai Pharma is up over 8 percent. The stock closed 58.4 percent higher yesterday following strong IPO pricing and debut.
For more color on Tokai's IPO, click here.
... More